{"url_path":"/sec/sbcww/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1930313/0001193125-26-222737-index.html","accession_number":"0001193125-26-222737","cik":"0001930313","ticker":"SBC","issuer_name":"SBC Medical Group Holdings Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1930313/0001193125-26-222737-index.html","primary_entity_key":"0001930313","primary_entity_name":"SBC Medical Group Holdings Inc"},"word_count":40,"has_tables":true,"body_markdown":"ITEM 5. OTHER INFORMATION\n\nRule 10b5-1 Trading Arrangements\n\nDuring the three months ended March 31, 2026, none of our directors or officers adopted, modified, or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.\n\n \n\n10\n\n[Table of Contents](#toc_page)"}